Cetera Investment Advisers
BMY icon

Cetera Investment Advisers’s Bristol-Myers Squibb BMY Stock Holding History

Cetera Investment Advisers’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$49.9M Buy
822,948
+40,910
+5% +$2.38M 0.05% 366
2025
Q4 		$42.2M Sell
782,038
-7,128
-0.9% -$343K 0.05% 402
2025
Q3 		$35.6M Buy
789,166
+196,411
+33% +$9.17M 0.04% 434
2025
Q2 		$27.4M Sell
592,755
-68,976
-10% -$3.39M 0.05% 408
2025
Q1 		$40.4M Buy
661,731
+25,022
+4% +$1.46M 0.08% 260
2024
Q4 		$36M Buy
636,709
+50,830
+9% +$2.84M 0.08% 261
2024
Q3 		$30.3M Buy
585,879
+37,673
+7% +$1.77M 0.07% 303
2024
Q2 		$22.8M Sell
548,206
-26,477
-5% -$1.18M 0.05% 365
2024
Q1 		$31.2M Buy
574,683
+415,984
+262% +$21.2M 0.07% 270
2023
Q4 		$8.14M Buy
158,699
+19,651
+14% +$1.03M 0.07% 275
2023
Q3 		$8.07M Sell
139,048
-26,605
-16% -$1.63M 0.07% 276
2023
Q2 		$10.6M Sell
165,653
-9,902
-6% -$664K 0.09% 208
2023
Q1 		$12.2M Buy
175,555
+8,074
+5% +$569K 0.11% 177
2022
Q4 		$12.1M Buy
167,481
+68,642
+69% +$5.18M 0.11% 171
2022
Q3 		$7.03M Sell
98,839
-48,217
-33% -$3.5M 0.14% 151
2022
Q2 		$11.3M Sell
147,056
-17,281
-11% -$1.32M 0.18% 116
2022
Q1 		$12M Buy
164,337
+4,460
+3% +$299K 0.17% 124
2021
Q4 		$9.97M Buy
159,877
+18,603
+13% +$1.09M 0.14% 155
2021
Q3 		$8.36M Sell
141,274
-11,800
-8% -$777K 0.13% 168
2021
Q2 		$10.2M Buy
153,074
+6,716
+5% +$438K 0.16% 139
2021
Q1 		$9.24M Sell
146,358
-13,257
-8% -$825K 0.18% 116
2020
Q4 		$9.9M Buy
159,615
+140,830
+750% +$8.66M 0.2% 113
2020
Q3 		$1.13M Sell
18,785
-611
-3% -$36.8K 0.09% 240
2020
Q2 		$1.14M Buy
19,396
+388
+2% +$23.2K 0.11% 211
2020
Q1 		$1.06M Buy
19,008
+360
+2% +$22K 0.13% 183
2019
Q4 		$1.19M Buy
18,648
+2,265
+14% +$130K 0.12% 186
2019
Q3 		$834K Sell
16,383
-1,014
-6% -$47.7K 0.1% 213
2019
Q2 		$789K Sell
17,397
-12,451
-42% -$580K 0.1% 215
2019
Q1 		$1.43M Buy
29,848
+253
+0.9% +$12.6K 0.2% 122
2018
Q4 		$1.54M Buy
29,595
+230
+0.8% +$12.4K 0.25% 107
2018
Q3 		$1.81M Sell
29,365
-2,898
-9% -$172K 0.26% 99
2018
Q2 		$1.79M Buy
32,263
+1,951
+6% +$105K 0.31% 84
2018
Q1 		$1.92M Sell
30,312
-2,809
-8% -$181K 0.36% 73
2017
Q4 		$2.03M Buy
33,121
+829
+3% +$51.9K 0.37% 69
2017
Q3 		$2.06M Buy
32,292
+4,431
+16% +$259K 0.46% 56
2017
Q2 		$1.55M Buy
27,861
+1,259
+5% +$68.5K 0.38% 76
2017
Q1 		$1.44M Buy
26,602
+2,372
+10% +$130K 0.4% 66
2016
Q4 		$1.42M Buy
24,230
+10,925
+82% +$597K 0.47% 58
2016
Q3 		$717K Sell
13,305
-7,320
-35% -$470K 0.31% 92
2016
Q2 		$1.51M Buy
20,625
+445
+2% +$31.4K 0.59% 43
2016
Q1 		$1.29M Buy
20,180
+1,315
+7% +$82.9K 0.56% 48
2015
Q4 		$1.3M Buy
+18,865
New +$1.25M 0.6% 46

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cetera Investment Advisers's BMY Position: Q1 2026 in Review

Cetera Investment Advisers increased its Bristol-Myers Squibb (BMY) stake by 5.2% in Q1 2026, buying an estimated $2.38M and bringing the position to 822,948 shares worth $49.9M. The position accounts for 0.05% of the portfolio, ranked #366.

Cetera Investment Advisers first reported a position in BMY in Q4 2015 and has held it in 42 quarters since. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Cetera Investment Advisers held 822,948 shares of Bristol-Myers Squibb worth $49.9M as of Q1 2026.
  • Cetera Investment Advisers bought 40,910 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.38M.
  • Bristol-Myers Squibb made up 0.05% of Cetera Investment Advisers's portfolio in Q1 2026, its #366 holding.
  • Cetera Investment Advisers first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 42 quarters since.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.